Sage Journals: Discover world-class research

Abstract

Studies involving economic analyses are being published with increasing frequency in medical and pharmacy literature. As members of pharmacy and therapeutics committees, or as clinicians dealing directly with patient management, pharmacists will be expected to evaluate published economic studies and apply results of such publications to their respective practice settings. The purpose of this article is to provide insight for practitioners into the evaluation of published pharmacoeconomic studies. Although pharmacoeconomic analyses may take many forms, there are several methodological concerns that are common to all. In light of this, we first discuss the evaluation of economic studies in general terms. Following this, two recently published pharmacoeconomic analyses are reviewed as examples of what one might consider in the critical evaluation of published pharmacoeconomic studies. Copyright © 1995 by W.B. Saunders Company

Get full access to this article

View all access options for this article.

References

Juergens JP , Szeinbach SL , Smith MC : Will future pharmacists understand pharmacoeconomic research. Am J Pharm Ed 56:135-140,1992

Muirhead G. : Hospital R.Ph.s lack knowledge of pharmacoeconomic studies. Hosp Pharm Report June 7:14,1993

Drummond MF , Stoddart GL , Torrance GW : Methods for the Economic Evaluation of Health Care Programmes. Oxford, UK, Oxford University Press, 1987

Langley PC : Outcomes research and modeling therapeutic interventions for economic evaluations . Clin Ther 16:538-552, 1994

Kaplan NM : Pitfalls in the interpretation of pharmacoeconomic studies. PharmacoEconomics 1:303-305, 1992

Larson LN : Cost determination and analysis, in Bootman JL , Townsend RJ , McGhan WF (eds): Principles of Pharmacoeconomics. Cincinnati, OH, Harvey Whitney Books Company, 1991, pp 34-49

Drummond MF , Davies L. : Economic analysis alongside clinical trials. Intl J Health Tech Assess 7:561-573, 1991

Krahn M. , Gafni A. : Discounting in the economic evaluation of health care interventions. Med Care 31:403-418, 1993

Coyle D. , Tolley K. : Discounting of health benefits in the pharmacoeconomic analysis of drug therapies: An issue for debate? PharmacoEconomics 2:153-162, 1992

10.

Katz DA , Welch HG : Discounting in cost-effectiveness analysis of healthcare programmes. PharmacoEconomics 3:276-285, 1993

11.

MacKeigan LD , Larson LN , Draugalis JR , et al: Time preference for health gains versus health losses. PharmacoEconomics 3:374-386,1993

12.

Drummond M. , O'Brien B. : Clinical importance, statistical significance and the assessment of economic and quality-of-life outcomes. Health Econ 2:205-212, 1993

13.

Briggs A. , Schulpher M. , Buxton M. : Uncertainty in the economic evaluation of health care technologies: The role of sensitivity analysis. Health Econ 3:95-104, 1994

14.

Bootman JL , Townsend RJ , McGhan WF (eds): Principles of Pharmacoeconomics. Cincinnati, OH , Harvey Whitney Books Company, 1991

15.

Hass SL , Lucas MJ : Net economic benefit of a manufactured dinoprostone gel for pre-induction cervical ripening. PharmacoEconomics 5:39-47, 1994

16.

Barr JT , Schumacher GE : Decision analysis and pharmacoeconomic evaluations, in Bootman JL , Townsend RJ , McGhan WF (eds): Principles of Pharmacoeconomics. Cincinnati, OH, Harvey Whitney Books Company, 1991, pp 112-133

17.

Einarson TR , McGhan WF , Bootman JL : Decision analysis applied to pharmacy practice . Am J Hosp Pharm 42:364-371, 1985

18.

Hillman AL , Eisenberg JM , Pauly MV , et al: Avoiding bias in the conduct and reporting of cost-effectiveness research sponsored by pharmaceutical companies. N Engl J Med 324:1362-1365, 1991

19.

Drummond MF : Economic evaluation of pharmaceuticals. Science or marketing? PharmacoEconomics 1:8-13, 1992

20.

Detsky AS : Guidelines for economic analysis of pharmaceutical products. A draft document for Ontano and Canada. PharmacoEconomics 3:354-361, 1993

21.

Coons SJ , Kaplan RM : Cost-utility analysis, in Bootman JL , Townsend RJ , McGhan WF (eds): Principles of Pharmacoeconomics, 2nd ed. Cincinnati, OH, Harvey Whitney Books Company, 1995 (In press)

22.

Weinstein MC , Stason WB : Foundations of cost-effectiveness analysis for health and medical practice. N Engl J Med 296:716-721, 1977

23.

Russell LB : Is Prevention Better Than Cure? Washington, DC, The Brookings Institution, 1986

24.

Torrance GW , Feeny D. : Utilities in quality-adjusted life years . Intl J Tech Assess Health Care 5:559-575, 1989

25.

Patrick DL , Erickson P. : Health Status and Health Policy: Allocating Resources to Health Care. New York, NY, Oxford University Press, 1993

26.

Weinstein MC , Stason WB : Cost-effectiveness of coronary artery bypass surgery. Circulation (Suppl 3):56-66, 1982

27.

Drummond M. : The role and importance of quality of life measurements in economic evaluations. Br J Med Econ 4:9-16,1992

28.

Boyle MH , Torrance GW , Sinclair JC , Horwood SP : Economic evaluation of neonatal intensive care of very-lowbirthweight infants. N Engl J Med 308:1330-1337, 1983

29.

Oldridge N. , Furlong W. , Feeny D. , Torrance G. , et al: Economic evaluation of cardiac rehabilitation soon after acute myocardial infarction. Am J Cardiol 72:154-161, 1993

30.

Goodwin PJ , Feld R. , Evans WK , Pater J. : Cost-effectiveness of cancer chemotherapy: An economic evaluation of a randomized trial in small cell lung cancer. J Clin Oncol 6:1537-1547, 1988

31.

Smith TJ , Hillner BE : The efficacy and cost-effectiveness of adjuvant therapy of early breast cancer in premenopausal women. J Clin Oncol 11:771-776, 1993

32.

Smith RD , Hall J. , Gurney H. , Harnett PR : A cost-utility approach to the use of 5-fluorouracil and levamisole as adjuvant chemotherapy for Dukes' C colonic carcinoma. Med J Aust 158:319-322, 1993

33.

Detsky AS , Naglie IG : A clinician's guide to cost-effectiveness analysis. Ann Intern Med 113:147-154, 1990

34.

Osterhaus JT , Draugalis JR : Applications of pharmacoeconomics for drug therapy decision, in Bootman JL , Townsend RJ , McGhan WF (eds): Principles of Pharmacoeconomics. Cincinnati, OH, Harvey Whitney Books Company, 1991, pp 134-145

35.

Lee JT , Sanchez LA : Interpretation of "cost-effective" and soundness of economic evaluations in the pharmacy literature. Am J Hosp Pharm 48:2622-2627, 1991

36.

Sacristan JA , Soto J. , Galende I. : Evaluation of pharmacoeconomic studies: Utilization of a checklist. Ann Pharmacother 27:1126-1133, 1993

Evaluation of Published Pharmacoeconomic Studies

Abstract

Get full access to this article

References